Skip to main content
. 2017 Sep 25;2017(9):CD011441. doi: 10.1002/14651858.CD011441.pub2

1.3. Analysis.

1.3

Comparison 1 Prophylaxis compared to on‐demand anti‐inhibitor coagulant complex (AICC) or factor eight inhibitor bypassing activity (FEIBA NF), Outcome 3 Target joint bleeding rate: number of hemarthroses.